Cognitive Behavioral Therapy for Schizophrenia
Cognitive Behavioral Therapy for Schizophrenia
复制标题
DOI：
10.1016/j.psc.2010.04.009
复制
发表时间：
2010-09-01
影响因子：
1.7
通讯作者：
Kingdon, David
中科院分区：
文献类型：
--
作者：
Rathod, Shanaya;Phiri, Peter;Kingdon, David
认知行为疗法（CBT）补充药物管理，证据表明其在管理阳性和阴性症状，促进治疗抵抗，改善精神分裂症的洞察力，依从性和攻击性方面的有效性。有新的证据表明，早期干预，共病药物滥用，减少复发和住院治疗。CBT现在被大多数精神分裂症临床指南推荐。治疗的基础是让患者参与治疗关系，制定一个商定的配方，然后使用一系列技术来治疗幻觉，妄想和阴性症状。本文就CBT治疗精神分裂症的现状作一综述。
Cognitive behavioral therapy (CBT) complements medication management and evidence has shown its effectiveness in managing positive and negative symptoms, promoting treatment resistance, and improving insight, compliance, and aggression in schizophrenia. There is emerging evidence in early intervention, comorbid substance misuse, and reducing relapse and hospitalization. CBT is now recommended by most clinical guidelines for schizophrenia. Treatment is based on engaging the patient in a therapeutic relationship, developing an agreed formulation, and then the use of a range of techniques for hallucinations, delusions, and negative symptoms. This article gives an overview of the current status of CBT for schizophrenia.